Schizophrenia and other psychotic disorders are highly debilitating psychiatric conditions
that lack a clear etiology and exhibit polygenic inheritance underlain by pleiotropic genes …

Neurodegenerative diseases (NDDs) are a group of diseases caused by chronic and
progressive degeneration of neural tissue. The main pathological manifestations are …

The three sets of symptoms associated with schizophrenia—positive, negative, and
cognitive—are burdensome and have serious effects on public health, which affects up to …

Identifying biomarkers that can be used as diagnostics or predictors of treatment response
(theranostics) in people with schizophrenia (Sz) will be an important step towards being able …

Parkinson's disease (PD) is the second most common neurodegenerative disorder
worldwide. Its main neuropathological hallmarks are the degeneration of dopaminergic …

Recently, increasing evidence has indicated that dysfunction of microRNA-124 (miR-124)
might be involved in the pathophysiology and treatment of major depressive disorder (MDD) …

Schizophrenia is associated with diverse changes in the brain's transcriptome and
proteome. Underlying these changes is the complex dysregulation of gene expression and …

Neuropsychiatric disorders are common health problems affecting approximately 1% of the
population. Twin, adoption, and family studies have displayed a strong genetic component …

There is an increasing interest in searching biomarkers for schizophrenia (SZ) diagnosis,
which overcomes the drawbacks inherent with the subjective diagnostic methods. MicroRNA …

Radiation exposure may induce Alzheimer's disease (AD), depression or schizophrenia. A
number of experimental and clinical studies suggest the involvement of miRNA in the …